Marion Subklewe

Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus.

R. Steinman, N. Bhardwaj, M. Subklewe, 1999, Blood.

Novel immunotherapies in the treatment of AML: is there hope?

N. Daver, D. Sallman, Marion Subklewe, 2023, Hematology. American Society of Hematology. Education Program.

Recognizing, defining, and managing CAR-T hematologic toxicities.

F. Locke, K. Rejeski, Marion Subklewe, 2023, Hematology. American Society of Hematology. Education Program.

CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations

Marion Subklewe, Nirali N. Shah, Fabiana Perna, 2024, Blood advances.